MIR4765: A Drug Target / Disease Biomarker (G100616219)
MIR4765: A Drug Target / Disease Biomarker
MIR4765, also known as interleukin-4765, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which is a group of cytokines that play a crucial role in the regulation of immune and inflammatory responses. MIR4765 has been shown to have various functions, including regulating the immune response, promoting cell survival, and influencing the development of cancer. As a result, MIR4765 has potential as a drug target or biomarker for a variety of diseases.
One of the most promising aspects of MIR4765 is its ability to regulate the immune response. MIR4765 has been shown to play a role in the regulation of T cell development and function. T cells are a crucial part of the immune system, and their development and function are tightly regulated by various signaling pathways. MIR4765 has been shown to regulate the growth and differentiation of T cells, as well as the production of antibodies by these cells.
In addition to its role in T cell regulation, MIR4765 has also been shown to have anti-inflammatory effects. Chronic inflammation is a major risk factor for a variety of diseases, including heart disease and cancer. MIR4765 has been shown to have a negative impact on the production of pro-inflammatory cytokines, such as TNF-alpha and IL-12, and to promote the production of anti-inflammatory cytokines, such as IL-10.
MIR4765 has also been shown to have potential as a drug target for cancer. The regulation of cell growth and apoptosis is a crucial aspect of cancer development, and MIR4765 has been shown to play a role in these processes. MIR4765 has been shown to promote the growth and survival of cancer cells, as well as to inhibit the production of angiogenesis, which is the process by which cancer cells grow into blood vessels that supply them with oxygen and nutrients.
MIR4765 has also been shown to have potential as a biomarker for a variety of diseases. The production of MIR4765 has been shown to be affected by a variety of factors, including stress, inflammation, and cancer. MIR4765 has been shown to have a positive correlation with the production of stress hormones, such as cortisol, and with the development of certain types of cancer, including breast and ovarian cancer.
In conclusion, MIR4765 is a protein that has a wide range of potential as a drug target or biomarker for a variety of diseases. Its ability to regulate the immune response and to promote cell survival in cancer cells makes it an attractive target for cancer therapies. Additionally, its ability to regulate the production of pro-inflammatory cytokines and to promote the production of anti-inflammatory cytokines makes it a potential target for diseases that are characterized by chronic inflammation. Further research is needed to fully understand the role of MIR4765 in these diseases and to develop safe and effective drugs or biomarkers based on this protein.
Protein Name: MicroRNA 4765
More Common Targets
MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2
